UC2288 |
A p21WAF1 inhibitor; reduces the protein levels and mRNA expression of p21… |
50 mg |
37380-50 |
More Info
|
UCB 9260 |
A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… |
10 mg |
37336-10 |
More Info
|
UCB 9260 |
A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… |
25 mg |
37336-25 |
More Info
|
UCB 9260 |
A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… |
5 mg |
37336-5 |
More Info
|
UCB 9260 |
A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… |
50 mg |
37336-50 |
More Info
|
UCF 101 |
A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… |
1 mg |
15550-1 |
More Info
|
UCF 101 |
A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… |
10 mg |
15550-10 |
More Info
|
UCF 101 |
A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… |
25 mg |
15550-25 |
More Info
|
UCF 101 |
A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… |
5 mg |
15550-5 |
More Info
|
UCLA gp130 2 |
A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… |
10 mg |
35551-10 |
More Info
|
UCLA gp130 2 |
A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… |
25 mg |
35551-25 |
More Info
|
UCLA gp130 2 |
A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… |
5 mg |
35551-5 |
More Info
|
UCLA gp130 2 |
A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… |
50 mg |
35551-50 |
More Info
|
UCL-TRO-1938 |
An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… |
1 mg |
39118-1 |
More Info
|
UCL-TRO-1938 |
An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… |
10 mg |
39118-10 |
More Info
|
UCL-TRO-1938 |
An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… |
5 mg |
39118-5 |
More Info
|
UCM05 |
An inhibitor of FASN that strongly suppresses the growth of human breast c… |
1 mg |
19090-1 |
More Info
|
UCM05 |
An inhibitor of FASN that strongly suppresses the growth of human breast c… |
10 mg |
19090-10 |
More Info
|
UCM05 |
An inhibitor of FASN that strongly suppresses the growth of human breast c… |
5 mg |
19090-5 |
More Info
|
UCM53 |
An inhibitor of bacterial cell division; binds to the GTP site of the cell… |
1 mg |
21768-1 |
More Info
|
UCM53 |
An inhibitor of bacterial cell division; binds to the GTP site of the cell… |
10 mg |
21768-10 |
More Info
|
UCM53 |
An inhibitor of bacterial cell division; binds to the GTP site of the cell… |
5 mg |
21768-5 |
More Info
|
UCM53 |
An inhibitor of bacterial cell division; binds to the GTP site of the cell… |
500 µg |
21768-500 |
More Info
|
UCM707 |
A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… |
10 mg |
10045-10 |
More Info
|
UCM707 |
A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… |
25 mg |
10045-25 |
More Info
|
UCM707 |
A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… |
5 mg |
10045-5 |
More Info
|
UCM707 |
A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… |
50 mg |
10045-50 |
More Info
|
UCN-01 |
A synthetic derivative of staurosporine that inhibits a variety of kinases… |
1 mg |
18130-1 |
More Info
|
UCN-02 |
A PKC inhibitor (IC50 = 62 nM) that is cytotoxic to the growth of HeLa S3… |
1 mg |
20221-1 |
More Info
|
UCN-02 |
A PKC inhibitor (IC50 = 62 nM) that is cytotoxic to the growth of HeLa S3… |
5 mg |
20221-5 |
More Info
|
UCPH-101 |
A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… |
1 mg |
21460-1 |
More Info
|
UCPH-101 |
A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… |
5 mg |
21460-5 |
More Info
|
UCPH-101 |
A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… |
500 µg |
21460-500 |
More Info
|
Udenafil |
A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… |
10 mg |
30373-10 |
More Info
|
Udenafil |
A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… |
25 mg |
30373-25 |
More Info
|
Udenafil |
A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… |
5 mg |
30373-5 |
More Info
|
Udenafil |
A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… |
50 mg |
30373-50 |
More Info
|
UDP-α-D-Galactose (sodium salt) |
A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… |
10 mg |
34664-10 |
More Info
|
UDP-α-D-Galactose (sodium salt) |
A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… |
25 mg |
34664-25 |
More Info
|
UDP-α-D-Galactose (sodium salt) |
A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… |
5 mg |
34664-5 |
More Info
|
UDP-α-D-Galactose (sodium salt) |
A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… |
50 mg |
34664-50 |
More Info
|
UDP-α-D-Glucose (sodium salt hydrate) |
An endogenous nucleotide sugar that binds the P2Y14 receptor (EC50 = 0.35… |
1 g |
15602-1 |
More Info
|
UDP-α-D-Glucose (sodium salt hydrate) |
An endogenous nucleotide sugar that binds the P2Y14 receptor (EC50 = 0.35… |
100 mg |
15602-100 |
More Info
|
UDP-β-D-Glucose (sodium salt) |
A stereoisomer of UDP-α-D-glucose |
1 g |
21620-1 |
More Info
|
UDP-β-D-Glucose (sodium salt) |
A stereoisomer of UDP-α-D-glucose |
100 mg |
21620-100 |
More Info
|
UDP-β-D-Glucose (sodium salt) |
A stereoisomer of UDP-α-D-glucose |
250 mg |
21620-250 |
More Info
|
UDP-β-D-Glucose (sodium salt) |
A stereoisomer of UDP-α-D-glucose |
500 mg |
21620-500 |
More Info
|
UDP-β-S (sodium salt) |
A P2Y6 receptor agonist; selectively induces inositol phosphate accumulati… |
2.1 mg |
38493-21 |
More Info
|
UDP-Glucuronic Acid (sodium salt hydrate) |
A source of glucuronic acid for polysaccharide biosynthesis; used for the… |
10 mg |
20674-10 |
More Info
|
UDP-Glucuronic Acid (sodium salt hydrate) |
A source of glucuronic acid for polysaccharide biosynthesis; used for the… |
25 mg |
20674-25 |
More Info
|
UDP-Glucuronic Acid (sodium salt hydrate) |
A source of glucuronic acid for polysaccharide biosynthesis; used for the… |
5 mg |
20674-5 |
More Info
|
UDP-N-acetyl-D-Galactosamine (sodium salt) |
A nucleotide sugar; used by glycosyltransferases to glycosylate various su… |
1 mg |
36506-1 |
More Info
|
UDP-N-acetyl-D-Galactosamine (sodium salt) |
A nucleotide sugar; used by glycosyltransferases to glycosylate various su… |
10 mg |
36506-10 |
More Info
|
UDP-N-acetyl-D-Galactosamine (sodium salt) |
A nucleotide sugar; used by glycosyltransferases to glycosylate various su… |
25 mg |
36506-25 |
More Info
|
UDP-N-acetyl-D-Galactosamine (sodium salt) |
A nucleotide sugar; used by glycosyltransferases to glycosylate various su… |
5 mg |
36506-5 |
More Info
|
UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) |
A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… |
10 mg |
20353-10 |
More Info
|
UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) |
A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… |
25 mg |
20353-25 |
More Info
|
UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) |
A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… |
50 mg |
20353-50 |
More Info
|
UDP (sodium salt hydrate) |
The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… |
1 g |
18137-1 |
More Info
|
UDP (sodium salt hydrate) |
The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… |
100 mg |
18137-100 |
More Info
|
UDP (sodium salt hydrate) |
The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… |
500 mg |
18137-500 |
More Info
|
U-47931E |
An analytical reference standard categorized as a utopioid; has antinocice… |
1 mg |
20530-1 |
More Info
|
U-47931E |
An analytical reference standard categorized as a utopioid; has antinocice… |
5 mg |
20530-5 |
More Info
|
U-48753E (maleate) |
A nontricyclic antidepressant that has been shown to modulate signaling th… |
1 mg |
20734-1 |
More Info
|
U-48753E (maleate) |
A nontricyclic antidepressant that has been shown to modulate signaling th… |
5 mg |
20734-5 |
More Info
|
UF010 |
A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… |
10 mg |
21273-10 |
More Info
|
UF010 |
A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… |
25 mg |
21273-25 |
More Info
|
UF010 |
A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… |
5 mg |
21273-5 |
More Info
|
UF010 |
A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… |
50 mg |
21273-50 |
More Info
|
UF-17 (hydrochloride) |
An analytical reference standard that is structurally similar to known uto… |
1 mg |
27925-1 |
More Info
|
UF-17 (hydrochloride) |
An analytical reference standard that is structurally similar to known uto… |
5 mg |
27925-5 |
More Info
|
UFP101 (trifluoroacetate salt) |
A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… |
1 mg |
36833-1 |
More Info
|
UFP101 (trifluoroacetate salt) |
A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… |
5 mg |
36833-5 |
More Info
|
UFP101 (trifluoroacetate salt) |
A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… |
500 µg |
36833-500 |
More Info
|
U-74389G |
U-74389G is an antioxidant which prevents iron-dependent lipid peroxidatio… |
100 mg |
75860-100 |
More Info
|